Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
Withers, Barbara, Blyth, Emily, Clancy, Leighton E., Yong, Agnes, Fraser, Chris, Burgess, Jane, Simms, Renee, Brown, Rebecca, Kliman, David, Dubosq, Ming-Celine, Bishop, David, Sutrave, Gaurav, Ma, Chun Kei Kris, Shaw, Peter J., Micklethwaite, Kenneth P., Gottlieb, David J.
Published in Blood advances (14.11.2017)
Published in Blood advances (14.11.2017)
Get full text
Journal Article
Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant
Gottlieb, David Jonathan, Clancy, Leighton Edward, Withers, Barbara, McGuire, Helen Marie, Luciani, Fabio, Singh, Mandeep, Hughes, Brendan, Gloss, Brian, Kliman, David, Ma, Chun Kei Kris, Panicker, Shyam, Bishop, David, Dubosq, Ming‐Celine, Li, Ziduo, Avdic, Selmir, Micklethwaite, Kenneth, Blyth, Emily
Published in Clinical & translational immunology (2021)
Published in Clinical & translational immunology (2021)
Get full text
Journal Article
A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial
Hertzberg, Mark, Matthews, Jane Palfrey, Stone, Janey Malka, Dubosq, Ming‐Celine, Grigg, Andrew, Ellis, David, Benson, Warwick, Browett, Peter, Horvath, Noemi, Januszewicz, Henry, Abdi, Ehtesham, Green, Michael, Bonaventura, Anthony, Marlton, Paula, Cannell, Paul, Wolf, Max
Published in American journal of hematology (01.05.2014)
Published in American journal of hematology (01.05.2014)
Get full text
Journal Article
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
Blyth, Emily, Clancy, Leighton, Simms, Renee, Ma, Chun K.K., Burgess, Jane, Deo, Shivashni, Byth, Karen, Dubosq, Ming-Celine, Shaw, Peter J., Micklethwaite, Kenneth P., Gottlieb, David J.
Published in Blood (02.05.2013)
Published in Blood (02.05.2013)
Get full text
Journal Article
Low-cost generation of Good Manufacturing Practice–grade CD19-specific chimeric antigen receptor–expressing T cells using piggyBac gene transfer and patient-derived materials
Ramanayake, Saumya, Bilmon, Ian, Bishop, David, Dubosq, Ming-Celine, Blyth, Emily, Clancy, Leighton, Gottlieb, David, Micklethwaite, Kenneth
Published in Cytotherapy (Oxford, England) (01.09.2015)
Published in Cytotherapy (Oxford, England) (01.09.2015)
Get full text
Journal Article
3rd Party CMV-Specific T Cells Provide Long Term Protection Against Episodes of Recurrent CMV after Allogeneic Stem Cell Transplant Despite Lack of Persistence in Peripheral Blood
Blyth, Emily, Withers, Barbara, Clancy, Leighton Edward, Yong, Agnes S.M., Fraser, Christopher, Burgess, Jane, Simms, Renee, Castellano Gonzalez, Gloria, Kliman, David, Dubosq, Ming-Celine, Bishop, David, Sutrave, Gaurav, Ma, Chun Kei Kris, Shaw, Peter J., Micklethwaite, Kenneth P., Gottlieb, David
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
449. Multipathogen-Specific T Cells for Immune Reconstitution – A Decade of Manufacturing Development and Clinical Use
Blyth, Emily, Clancy, Leighton, Simms, Renee, Burgess, Jane, Withers, Barbara, Kei Ma, Chun, Bishop, David, Dubosq, Ming-Celine, Micklethwaite, Kenneth, Gottlieb, David
Published in Molecular therapy (01.05.2015)
Published in Molecular therapy (01.05.2015)
Get full text
Journal Article